Liver Diseases Symposium Register

1150 West Magic Way, Anaheim, CA 92802

The 16th Annual UCLA Liver Diseases Symposium will provide a state-of-the-art update and scientific exchange on prevalent liver diseases and their complications using a multi-disciplinary approach with hepatologists, radiologists and surgeons.

Target Audience: Hepatologists, Radiologists, Surgeons, Nurses, Allied Healthcare Professionals, Fellows, and Residents.

16th Annual UCLA Liver Diseases Symposium Brochure (PDF)


To register using a credit card or ACH/electronic transfer, please click the register button on top.*
*Credit card and check payments via phone, fax, or mail are no longer accepted.

Course Fee

$50 Physicians
$35 Nurses and Other Allied Healthcare Professionals
$25 Fellows and Residents


Due to the low enrollment fee, no refunds will be offered. A full refund will be provided if this course is cancelled, or postponed.


If you have questions about enrollment, please email or call (310) 794-2620.


Disneyland Hotel
1150 West Magic Way
Anaheim, CA 92802
Magic Kingdom 2 & 3

Online Guest Room Reservations

Make your room reservation now! The special rate for the conference is $525.00. A limited number of rooms are reserved at this rate. To secure a room please contact the Disneyland® Resort by booking online 24/7 at or by calling (714) 520-5005, M-F from 8 am to 5 pm PST. Reservations must be made by  Monday, September 11, 2023 your cutoff date or before the group rooms are sold out, so do not delay. Prevailing rates may apply after this date or when the group rooms are sold out, whichever occurs first. Rooms are subject to availability.

Discounted Special Group Theme Park Tickets

Discounted Special Group Theme Park Tickets available to purchase online via the same URL ( The online ticket store within that link is now open. And the online ticket store will close Friday, October 13, 2023 9:00 PM PST.

These special ticket prices are not available once you arrive at the Resort.

Prices are subject to change without notice.

Conference Parking
Self-parking is $35


Please email


At the conclusion of this program, participants will be able to:

  • Diagnose and develop a treatment strategy for acute kidney injury in patients with cirrhosis.
  • Identify indications and evaluation for liver transplantation, as well as the role of MELD in organ allocation.
  • Review the pros and cons of Transjugular Intrahepatic Portosystemic Shunts (TIPS) in patients with cirrhosis and portal hypertension, including expanding indications.
  • Implement new and novel strategies for the treatment of hepatocellular carcinoma (HCC).
  • Discuss specific liver disorders and injuries in women, as well as pregnancy hepatic complications.
  • Treat non-alcoholic fatty liver disease and be able to employ noninvasive tests for diagnosis and risk stratification.
  • Review the treatment of alcohol hepatitis, including long-term follow up, and understand controversies associated with early liver transplantation.
  • Discuss updates in the management of patients with viral hepatitis B, including those immunotolerant, and considerations for stopping antiviral therapy.
  • Diagnose acute liver failure, and risk stratify patients according to available laboratory results and clinical parameters.



The David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The David Geffen School of Medicine at UCLA, designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved for the AMA PRA Category 1 Credits™ as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

The American Board for Transplant Certification (ABTC) has approved this educational offering for up to 4 Category One Continuing Education Points for Transplant Certification (CEPTCs).


The FDA has issued a concept paper that classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is “truly independent” and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manage all identified potential conflicts of interest prior to the program. UCLA fully endorses the letter and spirit of these concepts.